The drug "Renitek" (in other countries known as "Enalapril") is recommended for use in high blood pressure as an antihypertensive drug.
The main active ingredient is enilaprilmaleate, the mass fraction of which in the tablet can be 5, 10 and 20 mg, depending on the release. The drug is produced in blisters for 7 pcs. and 100 pieces each. in bottles of dark color. Depending on the mass of the main active substance, the tablets differ in color: white color - 5 mg, pink color - 10 mg, light pink color with a yellowish tone - 20 mg. In other respects, the appearance of the tablets is similar: they have a triangular shape with an engraved inscription "MSD 712" (white tablets), "MSD 713" (tablets of pink color) "MSD 714" (light pink color of the tablet) and with a risk on the back. As auxiliary substances in the "Renitek" tablet, the following ingredients are called the instruction for use: lactose, sodium hydrogen carbonate, corn starch, magnesium stearate, pregelatinized starch, red iron oxide (in a pink tablet) or yellow iron oxide (in a tablet of light pink colors).
The drug "Renitek" is appointed by the doctor in the case of the presence of the following diseases:
Before the start of the drug "Renitek"the instruction for use prescribes to undergo a medical examination, which will allow you to adjust the dose of the incoming substance based on the state of health of the individual patient. At the beginning of treatment, the dose of the drug should not exceed 10 mg / day. The maximum possible - 40 mg / day. With heart failure, the drug should be started with a dose of no more than 2.5 mg, later it can be increased to 10-20 mg / day. Reception of a medicine is not connected in any way with time of the use of food.
In order to avoid possible negative consequences, it is necessary to familiarize yourself with the contraindications to the reception of the "Renitek" preparation, the description of which is given below:
In addition to the presence of contraindications in the treatment of "Renitek" tablets, the instructions for use warn of possible side effects, such as:
The drug is strongly not recommended for breastfeeding and pregnant women.
There is incongruity of some drugs and components of the drug "Renitek", the instruction for use informs about it. It should avoid simultaneous reception with:
Another version of the drug - "Ko-Renitek." The instruction for its use is similar to the instruction "Reniteka" with the only difference that the composition of "Ko-Reniteka" includes hydrochlorothiazide, which has a diuretic effect.
In addition, it is necessary to familiarize yourself with possible side effects:
When an overdose of the drug, which is expressed in severe arterial hypotension, you should consult your doctor.
Shelf life "Reniteka" is 2.5 years. Store the drug in a dry place at room temperature.
This instruction is for informational purposes; before using, it is necessary to get medical advice.